
Biocurrent, Inc. is an early-stage bioelectronic medicine company focused on non-invasive brain wave modulation. The company has developed an AI-driven device and software application that creates an infinite feedback loop with the body to modulate human brain waves, addressing neurological problems and cellular damage. Biocurrent differentiates itself through its innovative technology that allows for in-home treatment via a mobile app, making healthcare more accessible. The founder, Andrew Blount, has a compelling personal story that drives the mission of the company, aiming to improve health outcomes for individuals suffering from chronic pain and other health issues. With a unique product offering and a strong vision for the future, Biocurrent is positioned to make a significant impact in the healthcare market.

Biocurrent, Inc. is an early-stage bioelectronic medicine company focused on non-invasive brain wave modulation. The company has developed an AI-driven device and software application that creates an infinite feedback loop with the body to modulate human brain waves, addressing neurological problems and cellular damage. Biocurrent differentiates itself through its innovative technology that allows for in-home treatment via a mobile app, making healthcare more accessible. The founder, Andrew Blount, has a compelling personal story that drives the mission of the company, aiming to improve health outcomes for individuals suffering from chronic pain and other health issues. With a unique product offering and a strong vision for the future, Biocurrent is positioned to make a significant impact in the healthcare market.
What they do: EEG-guided, non-invasive electro-medical device and software for brain-wave modulation and pain management
Stage & funding: Seed-stage; reported seed round in Feb 2022 with founder Andrew Blount as lead/backing investor
Founded / HQ: Founded 2022; headquartered in Henderson, Nevada, United States
Founder / CEO: Andrew Blount
Neurological disorders and chronic pain management
2022
Biotechnology
Seed round listed Feb 2022; company fact sheet and profiles report founder involvement in funding
“Founder-led seed investment (Andrew Blount)”